Mirogabalin and emerging therapies for diabetic neuropathy
Saad Javed,1,2 Uazman Alam,3–5 Rayaz A Malik1,2,6 1Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK; 2Manchester University Hospital, Manchester, UK; 3Diabetes and Endocrinology Research, Department of Eye and Vision Sciences and Pain Research Institute,...
Main Authors: | Javed S, Alam U, Malik RA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-08-01
|
Series: | Journal of Pain Research |
Subjects: | |
Online Access: | https://www.dovepress.com/mirogabalin-and-emerging-therapies-for-diabetic-neuropathy-peer-reviewed-article-JPR |
Similar Items
-
Mirogabalin - the use of a new gabapentinoid in the treatment of diabetic neuropathy and postherpetic neuropathy and other conditions
by: Weronika Gawel, et al.
Published: (2023-01-01) -
Safety, tolerability, and efficacy of a selective gabapentinoid mirogabalin in neuropathic pain—a topical review
by: Abhijit Nair, et al.
Published: (2021-10-01) -
Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients
by: Mitsuru Sugimoto, et al.
Published: (2021-12-01) -
Clinical Effectiveness of Mirogabalin Besylate for Trigeminal Neuropathy after Skull Base Surgery: Illustrative Cases
by: Kosuke Karatsu, et al.
Published: (2023-08-01) -
Long‐term safety and efficacy of mirogabalin in Asian patients with diabetic peripheral neuropathic pain
by: Masayuki Baba, et al.
Published: (2020-05-01)